The Effect of Antiemetics on Bowel Preparation Before Colonoscopy
NCT ID: NCT04583111
Last Updated: 2020-10-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
200 participants
INTERVENTIONAL
2020-03-01
2022-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Prokinetic Agents in Improving Abdominal Discomfort at Colonoscopy
NCT04104867
The Best Dosage and Timing of Polyethylene Glycol for Bowel Preparation Before Capsule Endoscopy
NCT02486536
Comparison Between 3-L and 4-L Polyethylene Glycol in Bowel Preparation
NCT03356015
Optimization of Intestinal Preparation in Older Patients
NCT05397158
Premedication Simethione Improves Visibility During Bowel Cleansing for Colonoscopy
NCT02540239
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Domperidone group
Patients in Domperidone group took 10mg of domperidone 30min before PEG.
Domperidone
Domperidone and sulpiride are antiemetics that may be useful in preventing the PEG-related nausea and vomiting.
Sulpiride group
Patients in Sulpiride group took 100mg of sulpiride 30min before PEG.
sulpiride
Domperidone and sulpiride are antiemetics that may be useful in preventing the PEG-related nausea and vomiting.
Control group
Patients in Control group followed the regular routine of 3L split-dose of PEG.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Domperidone
Domperidone and sulpiride are antiemetics that may be useful in preventing the PEG-related nausea and vomiting.
sulpiride
Domperidone and sulpiride are antiemetics that may be useful in preventing the PEG-related nausea and vomiting.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* allergy to domperidone, sulpiride or PEG;
* pregnancy or breastfeeding;
* previous use of prokinetics within 1 month.
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
RenJi Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shengliang Chen
Deputy director of the Division of Gastroenterology and Hepatology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shengliang Chen
Shanghai, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RJYYXHNK-006
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.